Inactive Instrument

News Ecology Coatings Inc Other OTC

Equities

US2788802088

End-of-day quote Other OTC Other stock markets
- ^USD	-

May. 17	ABVC BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Abvc Biopharma, Inc. Enters into A Definitive Agreement with Oncox Biopharma, Inc	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ABVC BioPharma Receives $296,000 Cash Out of Potential Aggregate License Fee of $24M Cash and Stock From Its Licensees AiBtl, ForSeeCon and OncoX in Global Licensing Deals	Jul. 02	AQ
Immunity Boosting Combination Therapy for Myelodysplastic Syndrome Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Eligible to Receive Aggregate Income of $13.75M and Royalties of up to $12.50M - Form 8-K	May. 24	PU
ABVC BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 17	CI
Promising Combination Therapy for Tripple Negative Breast Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, Potential Income of $13.75M and Royalties of up to $12.50M - Form 8-K	May. 15	PU
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M	May. 09	AQ
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M - Form 8-K	May. 09	PU
Abvc Biopharma, Inc. Enters into A Definitive Agreement with Oncox Biopharma, Inc	May. 09	CI
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share	Apr. 18	AQ
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M	Apr. 17	AQ
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M	Apr. 10	AQ
ABVC BioPharma, Inc., BioLite, Inc. and Rgene Corporation Enter Term Sheet with OncoX BioPharma, Inc	Apr. 10	CI
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M	Mar. 26	AQ
ABVC BioPharma, Inc. and BioFirst Corporation Enter Global Licensing Agreement with ForSeeCon Eye Corporation	Mar. 26	CI
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars	Mar. 21	AQ
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine	Mar. 19	AQ
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update	Mar. 14	AQ
ABVC BioPharma : Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update - Form 8-K	Mar. 14	PU
ABVC BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
ABVC BioPharma Signs Licensing Deal With Senior Paradise	Feb. 15	MT
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues	Feb. 15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ecology Coatings Inc Other OTC

Equities

US2788802088

Summary

Filters